Loading...
XETR
MED
Market cap219mUSD
Jul 09, Last price  
4.04EUR
1D
0.00%
1Q
14.12%
Jan 2017
-31.18%
IPO
-63.47%
Name

Mediclin AG

Chart & Performance

D1W1MN
XETR:MED chart
P/E
7.53
P/S
0.24
EPS
0.54
Div Yield, %
0.99%
Shrs. gr., 5y
Rev. gr., 5y
3.52%
Revenues
784m
+4.77%
378,498,000391,965,000456,795,000470,579,000487,167,000493,563,000509,739,000514,954,000538,035,000555,348,000580,344,000609,100,000645,100,000673,100,000659,900,000673,100,000704,700,000730,100,000748,800,000784,490,056
Net income
25m
+2.61%
05,729,0007,273,00010,359,00010,100,0002,977,000-1,403,000-2,638,0008,503,00016,536,00016,546,0003,908,0007,717,0009,662,000-8,997,0001,461,0009,441,000-10,776,00024,839,00025,486,439
CFO
100m
+23.96%
13,387,30016,412,98021,530,32732,346,21013,366,07815,625,58216,173,0149,953,46732,127,46928,923,00829,903,18819,342,79929,675,06669,593,300118,690,44981,966,68834,639,49778,001,32280,565,95299,868,469
Dividend
Jun 05, 20250.04 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Mediclin AG is a German healthcare enterprise primarily engaged in managing hospitals across the nation. Its operations are categorized into three main segments: Post-Acute, Acute, and various other related activities. The company offers a comprehensive range of medical specializations, encompassing fields such as neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, and surgical interventions, in addition to general nursing care. Furthermore, Mediclin provides specialized services like ear, nose, and throat (ENT) treatment and acute outpatient care. As of December 31, 2021, its extensive network comprised 34 clinics, 7 nursing care facilities, and 11 medical care centres. This infrastructure collectively provided a significant capacity of 7,831 beds and 482 nursing places, distributed across eleven of Germany's federal states. The company's corporate headquarters are situated in Offenburg, Germany.
IPO date
Dec 04, 2000
Employees
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT